ACCESSION: MSBNK-SMB_Measured-HSA014P0374002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'EL08-neg_8886': {'bp': 951326.0, 'sum': 1430668.0}, 'EL18-neg_8879': {'bp': 888180.0, 'sum': 1355704.0}, 'EL07-neg_8881': {'bp': 817248.0, 'sum': 1247585.0}, 'EL10-neg_8874': {'bp': 802672.0, 'sum': 1228691.0}, 'EL06-neg_8914': {'bp': 756140.0, 'sum': 1140679.0}, 'EL11-neg_8863': {'bp': 714530.0, 'sum': 1079039.0}, 'EL03-neg_8873': {'bp': 659779.0, 'sum': 988509.0}, 'EL09-neg_8887': {'bp': 659594.0, 'sum': 997312.0}, 'EL22-neg_8941': {'bp': 594519.0, 'sum': 900535.0}, 'EL17-neg_8898': {'bp': 575304.0, 'sum': 849149.0}, 'EL07-neg_8915': {'bp': 536675.0, 'sum': 789599.0}, 'EL01-neg_8871': {'bp': 497303.0, 'sum': 727573.0}, 'EL05-neg_8918': {'bp': 457730.0, 'sum': 696024.0}, 'EL14-neg_8886': {'bp': 438560.0, 'sum': 633179.0}, 'EL16-neg_8880': {'bp': 374738.0, 'sum': 570925.0}, 'EL02-neg_8960': {'bp': 329102.0, 'sum': 509562.0}, 'EL20-neg_8909': {'bp': 320323.0, 'sum': 483792.0}, 'EL24-neg_8862': {'bp': 285105.0, 'sum': 420746.0}, 'EL23-neg_8893': {'bp': 265715.0, 'sum': 397745.0}, 'EL11-neg_8900': {'bp': 177886.0, 'sum': 266140.0}, 'EL18-neg_8915': {'bp': 159558.0, 'sum': 235626.0}}
COMMENT: RETENTION_TIME_STDEV 0.019
COMMENT: PRECURSOR_M/Z_RAW 374.244622
COMMENT: PRECURSOR_M/Z_STDEV 0.000131
COMMENT: PRECURSOR_IN_MS1 mz 374.244653; int 37.002; delta(ppm) 1.348412
COMMENT: PROPOSED_CHARGE_STATE -1; mz 375.247889; int 8.143; cor 0.950
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 410.221399; int 11.813; cor 0.956
COMMENT: PROPOSED_ION_FORM M-H; M+FA-H; mz 420.250349; int 94.245; cor 0.953
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 2.382; C13H39N5O3P2; [M-H]1; delta(ppm) -2.382400
COMMENT: PROPOSED_MF SevenGoldenRules 0.736; C21H33N3O3; [M-H]1; delta(ppm) -0.735506
COMMENT: PROPOSED_MF MS-FINDER 3.775; C21H33N3O3; [M-H]-; delta(ppm) -0.736173
COMMENT: PROPOSED_MF MS-FINDER 3.022; C13H37N5O5S; [M-H]-; delta(ppm) 1.004971
COMMENT: PROPOSED_MF MS-FINDER 2.999; C15H34N7O2P; [M-H]-; delta(ppm) 2.025555
COMMENT: PROPOSED_MF MS-FINDER 2.932; C14H33N9OS; [M-H]-; delta(ppm) -2.568659
COMMENT: PROPOSED_MF MS-FINDER 2.087; C14H41N5S3; [M-H]-; delta(ppm) -1.317086
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.124; C21H33N3O3; [M-H]-; delta(ppm) -0.736173
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C21H33N3O3; [M-H]-; delta(ppm) -0.736173
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.514; C21H33N3O3; [M-H]-; delta(ppm) -0.736173
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.568; C23H35O4; [M-H]-; delta(ppm) -4.323818
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.097; C18H34FN3O4; [M-H]-; delta(ppm) -3.789386
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.317; C17H29N9O; [M-H]-; delta(ppm) 6.439194
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.159; C15H34N7O2P; [M-H]-; delta(ppm) 2.025555
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.825; C19H38NO4P; [M-H]-; delta(ppm) -5.149749
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.745; C19H30FN7; [M-H]-; delta(ppm) -7.362982
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.000; C19H31N6O2; [M-H]-; delta(ppm) 2.851497
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.280; C16H34ClN7O; [M-H]-; delta(ppm) -60263.096722
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.689; C20H38ClNO3; [M-H]-; delta(ppm) -60269.433249
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.974; C21H33N3O3; [M-H]-; delta(ppm) -0.736173
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.017; C23H35O4; [M-H]-; delta(ppm) -4.323818
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C18H34FN3O4; [M-H]-; delta(ppm) -3.789386
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C15H34N7O2P; [M-H]-; delta(ppm) 2.025555
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C17H29N9O; [M-H]-; delta(ppm) 6.439194
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C19H30FN7; [M-H]-; delta(ppm) -7.362982
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C19H38NO4P; [M-H]-; delta(ppm) -5.149749
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.608; PVERDUFTDYLFAY-WXWVCVOLNA-N; [M-H]-; CC[C@H]1O[C@@]2(C[C@H]3CC[C@H]4C[C@@]5(NC(=N2)N34)O[C@@H](C)CC[C@H]5O)CCC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.471; KWSQSLXUCMXPFT-UHFFFAOYSA-N; [M-H]-; O=C1NC(C(=O)N2CCN(C(=O)C3CCCCC3)CC12)CC4CCCCC4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.442; SWKFANOTEGEVNM-UHFFFAOYSA-N; [M-H]-; O=C(O)C1=C2CC3C4(CCCC4)CC(C)C2(CC1O)C3(C)CNC(=N)NC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.375; OXHIJBISUPBBOF-UHFFFAOYSA-N; [M-H]-; O=C(N)NN=C1CC23CCC4C(C(=O)O)(C)CCCC4(C)C3CCC1(C)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.373; QYQGFEWDRQKXIR-UHFFFAOYSA-N; [M-H]-; OC1C(NCC2CCCCC2)C3OC(OC3)C1N(C)CCC4=NC=CC=C4
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.320; PVERDUFTDYLFAY-WXWVCVOLNA-N; [M-H]-; UNPD28692
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.218; RVSVDDLHJYAACK-UHFFFAOYSA-N; [M-H]-; CNP0443965
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.188; MLGCDOQQOPHUAX-UHFFFAOYSA-N; [M-H]-; 2-[3-ethyl-1-(pyridine-3-carbonyl)piperidin-4-yl]-N-(1-hydroxy-4-methylpentan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.135; SWKFANOTEGEVNM-UHFFFAOYSA-N; [M-H]-; 3'-hydroxy-10',11'-dimethyl-11'-[(N'-methylcarbamimidamido)methyl]spiro[cyclopentane-1,8'-tricyclo[5.3.1.0?,?]undecan]-4'-ene-4'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.071; KWSQSLXUCMXPFT-UHFFFAOYSA-N; [M-H]-; 8-cyclohexanecarbonyl-3-(cyclohexylmethyl)-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.872; VAFNVNSIPJPTCO-UHFFFAOYSA-N; [M-H]-; CNP0446355
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.870; QYQGFEWDRQKXIR-UHFFFAOYSA-N; [M-H]-; CNP0443006
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.856; NJPGXAWJOOZZSK-UHFFFAOYSA-N; [M-H]-; 1-(2-methoxyethyl)-3-(4-methoxyphenyl)-1-[(octahydro-1H-quinolizin-1-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.845; VNWIGWWSJQLIDM-UHFFFAOYSA-N; [M-H]-; CNP0446884
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.845; ZLPITHGIDOIWHH-UHFFFAOYSA-N; [M-H]-; 1-(2-methoxyethyl)-4,6-dimethyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.844; LGHOQGJXSWWDLY-UHFFFAOYSA-N; [M-H]-; N-cyclohexyl-3-ethyl-4-({[(furan-2-yl)methyl]carbamoyl}methyl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.773; LGMKNZMQTXSHAP-UHFFFAOYSA-N; [M-H]-; 3-ethyl-4-({[(4-methoxyphenyl)methyl]carbamoyl}methyl)-N-(propan-2-yl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.533; OXHIJBISUPBBOF-UHFFFAOYSA-N; [M-H]-; 14-[(carbamoylamino)imino]-5,9,13-trimethyltetracyclo[11.2.1.0?,??.0?,?]hexadecane-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.525; AKCBHBQPJNWHSC-UHFFFAOYSA-N; [M-H]-; CNP0427319
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.525; VJWMPGDTTOSZMW-UHFFFAOYSA-N; [M-H]-; 2-[1-benzoyl-3-(2-{[2-(dimethylamino)ethyl](methyl)azaniumyl}ethyl)piperidin-4-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SWKFANOTEGEVNM-UHFFFAOYSA-N; [M-H]-; 3'-hydroxy-10',11'-dimethyl-11'-[(N'-methylcarbamimidamido)methyl]spiro[cyclopentane-1,8'-tricyclo[5.3.1.0?,?]undecan]-4'-ene-4'-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; VNWIGWWSJQLIDM-UHFFFAOYSA-N; [M-H]-; CNP0446884
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.900; VJWMPGDTTOSZMW-UHFFFAOYSA-N; [M-H]-; 2-[1-benzoyl-3-(2-{[2-(dimethylamino)ethyl](methyl)azaniumyl}ethyl)piperidin-4-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; PVERDUFTDYLFAY-WXWVCVOLNA-N; [M-H]-; UNPD28692
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.831; RVSVDDLHJYAACK-UHFFFAOYSA-N; [M-H]-; CNP0443965
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.822; MLGCDOQQOPHUAX-UHFFFAOYSA-N; [M-H]-; 2-[3-ethyl-1-(pyridine-3-carbonyl)piperidin-4-yl]-N-(1-hydroxy-4-methylpentan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.763; AKCBHBQPJNWHSC-UHFFFAOYSA-N; [M-H]-; CNP0427319
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.366; LGHOQGJXSWWDLY-UHFFFAOYSA-N; [M-H]-; N-cyclohexyl-3-ethyl-4-({[(furan-2-yl)methyl]carbamoyl}methyl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.356; VAFNVNSIPJPTCO-UHFFFAOYSA-N; [M-H]-; CNP0446355
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.347; ZLPITHGIDOIWHH-UHFFFAOYSA-N; [M-H]-; 1-(2-methoxyethyl)-4,6-dimethyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.324; NJPGXAWJOOZZSK-UHFFFAOYSA-N; [M-H]-; 1-(2-methoxyethyl)-3-(4-methoxyphenyl)-1-[(octahydro-1H-quinolizin-1-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.317; LGMKNZMQTXSHAP-UHFFFAOYSA-N; [M-H]-; 3-ethyl-4-({[(4-methoxyphenyl)methyl]carbamoyl}methyl)-N-(propan-2-yl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.312; KWSQSLXUCMXPFT-UHFFFAOYSA-N; [M-H]-; 8-cyclohexanecarbonyl-3-(cyclohexylmethyl)-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.312; QYQGFEWDRQKXIR-UHFFFAOYSA-N; [M-H]-; CNP0443006
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.037; OXHIJBISUPBBOF-UHFFFAOYSA-N; [M-H]-; 14-[(carbamoylamino)imino]-5,9,13-trimethyltetracyclo[11.2.1.0?,??.0?,?]hexadecane-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; CPEULHAPWXMDDV-UHFFFAOYSA-N; [M-H]-; N-[3,5-bis(2,2-dimethylpropanoylamino)phenyl]-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.825; UVWQGMJLTOOEGV-UHFFFAOYSA-N; [M-H]-; N-[3-[(2,4-dimethoxyphenyl)methylamino]propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; XBYILEKMFVLNDJ-UHFFFAOYSA-N; [M-H]-; [6-[5-(diethylamino)pentan-2-ylamino]-5,8-dimethoxyquinolin-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; NYYSFOJJGVOLRP-UHFFFAOYSA-N; [M-H]-; 1-cyclohexyl-3-[4-[3-(cyclopentylamino)-2-hydroxypropoxy]phenyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; SSFDRNFMNOYJQN-UHFFFAOYSA-N; [M-H]-; ethyl 5-[2-(dipropylamino)acetyl]-4-methyl-1,2,3,4-tetrahydro-1,5-benzodiazepine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; NPRUBRKIDPMLSI-UHFFFAOYSA-N; [M-H]-; [6-[5-(diethylamino)pentan-2-ylamino]-5,8-dimethoxyquinolin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; YETNAJXRRQTUPV-HKUYNNGSSA-N; [M-H]-; (2S)-N-butyl-1-[(2S)-2-[(2-hydroxyphenyl)methylamino]-3-methylbutanoyl]pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.524; CPEULHAPWXMDDV; [M-H]-; 1,3,5-Tris(2,2-dimethylpropionylamino)benzene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.550; KWSQSLXUCMXPFT; [M-H]-; (7S,9aS)-2-(cyclohexanecarbonyl)-7-(cyclohexylmethyl)-1,3,4,7,8,9a-hexahydropyrazino[1,2-a]pyrazine-6,9-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.837; LGMKNZMQTXSHAP; [M-H]-; (3R,4S)-3-ethyl-4-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-N-propan-2-ylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -361.373; ZLPITHGIDOIWHH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -375.504; NJPGXAWJOOZZSK; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -379.290; LGHOQGJXSWWDLY; [M-H]-; (3R,4S)-N-cyclohexyl-3-ethyl-4-[2-(furan-2-ylmethylamino)-2-oxoethyl]piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.203; VJWMPGDTTOSZMW; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.902; MLGCDOQQOPHUAX; [M-H]-; 2-[(3R,4S)-3-ethyl-1-(pyridine-3-carbonyl)piperidin-4-yl]-N-[(2R)-1-hydroxy-4-methylpentan-2-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -439.071; NPRUBRKIDPMLSI; [M-H]-; [6-[5-(diethylamino)pentan-2-ylamino]-5,8-dimethoxyquinolin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -451.692; XBYILEKMFVLNDJ; [M-H]-; [6-[5-(diethylamino)pentan-2-ylamino]-5,8-dimethoxyquinolin-4-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -463.409; NYYSFOJJGVOLRP; [M-H]-; 1-cyclohexyl-3-[4-[3-(cyclopentylamino)-2-hydroxypropoxy]phenyl]urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -477.933; VNWIGWWSJQLIDM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -498.089; RVSVDDLHJYAACK; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -511.400; QYQGFEWDRQKXIR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -529.474; AKCBHBQPJNWHSC; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -531.312; SSFDRNFMNOYJQN; [M-H]-; ethyl 5-[2-(dipropylamino)acetyl]-4-methyl-1,2,3,4-tetrahydro-1,5-benzodiazepine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -548.898; VAFNVNSIPJPTCO; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -568.723; OXHIJBISUPBBOF; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -665.772; PVERDUFTDYLFAY; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -726.062; SWKFANOTEGEVNM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.279; CPEULHAPWXMDDV; [M-H]-; 1,3,5-Tris(2,2-dimethylpropionylamino)benzene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -279.060; CPEULHAPWXMDDV; [M-H]-; 1,3,5-Tris(2,2-dimethylpropionylamino)benzene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -405.386; LGMKNZMQTXSHAP; [M-H]-; 3-ethyl-4-({[(4-methoxyphenyl)methyl]carbamoyl}methyl)-N-(propan-2-yl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -443.465; KWSQSLXUCMXPFT; [M-H]-; 8-cyclohexanecarbonyl-3-(cyclohexylmethyl)-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-1,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -471.969; LGHOQGJXSWWDLY; [M-H]-; N-cyclohexyl-3-ethyl-4-({[(furan-2-yl)methyl]carbamoyl}methyl)piperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -512.034; VJWMPGDTTOSZMW; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -514.692; ZLPITHGIDOIWHH; [M-H]-; 1-(2-methoxyethyl)-4,6-dimethyl-N-[(octahydro-1H-quinolizin-1-yl)methyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -537.440; MLGCDOQQOPHUAX; [M-H]-; 2-[3-ethyl-1-(pyridine-3-carbonyl)piperidin-4-yl]-N-(1-hydroxy-4-methylpentan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -610.173; SSFDRNFMNOYJQN; [M-H]-; 1H-1,5-Benzodiazepine-2-carboxylic acid, 2,3,4,5-tetrahydro-5-((dipropylamino)acetyl)-4-methyl-, ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -627.221; NJPGXAWJOOZZSK; [M-H]-; 1-(2-methoxyethyl)-3-(4-methoxyphenyl)-1-[(octahydro-1H-quinolizin-1-yl)methyl]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -638.357; OFRLZINXGXFKCB; [M-H]-; N-[(1S,3S)-2,2-dimethyl-3-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methyl]cyclobutyl]cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.405; CPEULHAPWXMDDV; [M-H]-; 1,3,5-Tris(2,2-dimethylpropionylamino)benzene
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C21H32N3O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 15.254
MS$FOCUSED_ION: PRECURSOR_M/Z 374.244640
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0009000000-a672e712d5c7a669ca23
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  101.0593028 13.5601 101.059317 0.7817 2.35 0.9289 17 f{C3H7N3O1}/-1.56ppm,p-C18H25O2
  232.1090391 99.3211 232.108858 0.7841 7.73 0.9909 21 f{C14H16O3}/-6.26ppm,p-C7H16N3
  290.1870689 26.4263 290.187299 1.0235 3.05 0.9714 21 f{C18H26O3}/-5.77ppm,p-C3H6N3
  374.2447638 999.0000 374.245237 0.3821 0.00 1.0000 21 f{C21H32N3O3}/-0.41ppm,p
  375.2478043 228.3327 375.248279 0.6822 8.36 0.9974 21 ?
  376.2512828 25.7878 376.251758 1.3980 4.81 0.9500 15 ?
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  101.059303 13.56 13
  232.109039 99.32 99
  290.187069 26.43 26
  374.244764 999.00 999
  375.247804 228.33 228
  376.251283 25.79 25
//
